Cencora (COR) Total Non-Current Liabilities (2009 - 2026)
Cencora's (COR) quarterly Total Non-Current Liabilities came in at -$3.1 billion in Q1 2026, down 9.97% YoY from -$3.5 billion in Q1 2025, and down 4.27% on a QoQ basis from -$3.0 billion in Q4 2025.
Cencora (COR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Cencora (COR) has 18 years of Total Non-Current Liabilities data on file, last reported at -$3.1 billion in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 9.97% year-over-year to -$3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 billion (down 9.97% YoY) and the FY2025 annual result came in at -$2.9 billion, down 1020.43% from the prior year.
- Total Non-Current Liabilities retreated to -$3.1 billion in Q1 2026, from -$3.0 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $320.5 million in Q3 2024 to a low of -$5.4 billion in Q2 2022.
- A 5-year average of -$2.0 billion and a median of -$1.5 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 203.1% — and 2023, when it plunged 2972.33%.
- Tracing COR's Total Non-Current Liabilities over 5 years: stood at $145.3 million in 2022, then sank by 2972.33% to -$4.2 billion in 2023, then soared by 64.32% to -$1.5 billion in 2024, then slumped by 100.51% to -$3.0 billion in 2025, then declined by 4.27% to -$3.1 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at -$3.1 billion (Q1 2026), -$3.0 billion (Q4 2025), and -$2.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 83.27 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -2.92 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 6.22 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | 2,565.00 |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 75.80 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 2.45 Bn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 251.86 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 38.31 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.92 Bn |
| Mar 31, 2026 | -3.11 Bn |
| Dec 31, 2025 | -2.99 Bn |
| Sep 30, 2025 | -2.95 Bn |
| Jun 30, 2025 | -3.64 Bn |
| Mar 31, 2025 | -2.83 Bn |
| Dec 31, 2024 | -1.49 Bn |
| Sep 30, 2024 | 320.47 Mn |
| Jun 30, 2024 | -4.15 Bn |
| Mar 31, 2024 | -1.37 Bn |
| Dec 31, 2023 | -4.17 Bn |
| Sep 30, 2023 | -1.30 Bn |
| Jun 30, 2023 | -1.25 Bn |
| Mar 31, 2023 | -564.79 Mn |
| Dec 31, 2022 | 145.29 Mn |
| Sep 30, 2022 | 147.18 Mn |
| Jun 30, 2022 | -5.40 Bn |
| Mar 31, 2022 | 287.83 Mn |
| Dec 31, 2021 | -5.50 Bn |
| Sep 30, 2021 | -5.55 Bn |